{"id":"W2069425136","doi":"10.3816/clc.2009.s.004","title":"Extending Outcomes: Epidermal Growth Factor Receptor–Targeted Monoclonal Antibodies in Non–Small-Cell Lung Cancer","year":2009,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cetuximab; Epidermal growth factor receptor; Medicine; Monoclonal antibody; Lung cancer; Tyrosine kinase; Cancer research; Targeted therapy; Oncology; Epidermal growth factor; Antibody; Cancer; Internal medicine; Immunology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006382333,0.0007164348,0.001461602,0.001538136,0.0001454365,0.0005884265,0.0006175867,0.0007730854,0.003352708],"category_scores_gemma":[0.0008098222,0.0002192108,0.0006541936,0.001524639,0.0002393074,0.0007934602,0.0003902177,0.001272551,0.001031229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005834842,"about_ca_system_score_gemma":0.0007657366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001022926,"about_ca_topic_score_gemma":0.003282785,"domain_scores_codex":[0.9998505,0.00002943254,0.00002784853,0.00002356655,0.00005153276,0.00001713207],"domain_scores_gemma":[0.9996794,0.0001699079,0.00007022603,0.000007015879,0.00005507921,0.00001838624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001597836,0.00007130273,0.0001655519,0.01191329,0.0001759,0.000130833,0.00001751288,0.0003238806,0.00111553,0.0009051735,0.02969135,0.9553298],"study_design_scores_gemma":[0.0003021814,0.0005027927,0.002341493,0.007464393,0.0009806356,0.002067031,0.00004383711,0.0002692729,0.001150901,0.001288359,0.9835613,0.0000277563],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002134332,0.9982609,0.00009935366,0.0003011131,0.0001634261,0.000007307378,0.00002260834,0.000007430172,0.0009244781],"genre_scores_gemma":[0.001734727,0.9967155,0.0001465906,0.0004434189,0.0001916547,0.000009945898,0.00004112157,0.000001416087,0.0007155688],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003352708,"threshold_uncertainty_score":0.01121593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07954086513988046,"score_gpt":0.4812353200448106,"score_spread":0.4016944549049302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}